Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: an emergent therapeutic target

Tuberculosis (TB) is the leading cause of death from a single infectious agent and in 2019 an estimated 10 million people worldwide contracted the disease. Although treatments for TB exist, continual emergence of drug-resistant variants necessitates urgent development of novel antituberculars. An im...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Adams, O, Deme, JC, Parker, JL, Fowler, PW, Lea, SM, Newstead, S
Beste egile batzuk: CRyPTIC Consortium
Formatua: Journal article
Hizkuntza:English
Argitaratua: Elsevier 2021